UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma

PloS one, 2010-08, Vol.5 (8), p.e12419-e12419

2010

Volltextzugriff (PDF)

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

The American journal of gastroenterology, 1999-09, Vol.94 (9), p.2467-2474

1999

Volltextzugriff (PDF)

Editorial: Feeling better about NASH

Alimentary pharmacology & therapeutics, 2023-08, Vol.58 (4), p.482-483

Di Bisceglie, Adrian M

2023

Volltextzugriff (PDF)

Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial

The American journal of gastroenterology, 2023-07, Vol.118 (7), p.1226-1236

2023

Volltextzugriff (PDF)

A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis

The American journal of gastroenterology, 2022-11, Vol.117 (11), p.1805-1815

2022

Volltextzugriff (PDF)

All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.115-126

2017

Volltextzugriff (PDF)

A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study

PloS one, 2018-08, Vol.13 (8), p.e0196908-e0196908

2018

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia

Lipids in health and disease, 2020-11, Vol.19 (1), p.1-10, Article 239

2020

Volltextzugriff (PDF)

Review article: Recommendations for detection, assessment and management of suspected drug‐induced liver injury during clinical trials in oncology patients

Alimentary pharmacology & therapeutics, 2024-11, Vol.60 (10), p.1293-1307

2024

Volltextzugriff (PDF)

Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components

PloS one, 2014-07, Vol.9 (7), p.e101422-e101422

2014

Volltextzugriff (PDF)

Genome-wide capture sequencing to detect hepatitis C virus at the end of antiviral therapy

BMC infectious diseases, 2020-08, Vol.20 (1), p.1-632, Article 632

2020

Volltextzugriff (PDF)

Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients

PloS one, 2010-02, Vol.5 (2), p.e9032

2010

Volltextzugriff (PDF)

A novel target enrichment strategy in next-generation sequencing through 7-deaza-dGTP-resistant enzymatic digestion

BMC research notes, 2020-09, Vol.13 (1), p.445-445, Article 445

2020

Volltextzugriff (PDF)

Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B

The American journal of gastroenterology, 2023-07, Vol.118 (7), p.1214-1225

2023

Volltextzugriff (PDF)

Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals

Journal of general internal medicine : JGIM, 2020-04, Vol.35 (4), p.1011-1020

2020

Volltextzugriff (PDF)

High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy

PloS one, 2014-06, Vol.9 (6), p.e100131

2014

Volltextzugriff (PDF)

Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection

PloS one, 2013-06, Vol.8 (6), p.e64992-e64992

2013

Volltextzugriff (PDF)

Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.1001-1011

2018

Volltextzugriff (PDF)

Changes in quality of life and sexual health are associated with low‐dose peginterferon therapy and disease progression in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2010-04, Vol.31 (7), p.719-734

2010

Volltextzugriff (PDF)

Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status

The American journal of gastroenterology, 2003-09, Vol.98 (9), p.2060-2063

2003

Volltextzugriff (PDF)

Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitis

Hepatology (Baltimore, Md.), 1991-12, Vol.14 (6), p.969-974

1991

Volltextzugriff (PDF)

A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients

Oncology reports, 2006-07, Vol.16 (1), p.133-140

2006

Volltextzugriff (PDF)

Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia

The American journal of gastroenterology, 2019-11, Vol.114 (11), p.1753-1763

2019

Volltextzugriff (PDF)

Clinical presentation and natural course of hepatocellular carcinoma

European journal of gastroenterology & hepatology, 2005-05, Vol.17 (5), p.485-489

2005

Volltextzugriff (PDF)

Phenotypes of Chronic Hepatitis B in Children From a Large North American Cohort

Journal of pediatric gastroenterology and nutrition, 2019-11, Vol.69 (5), p.588-594

2019

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Aktive Filter

KollektionIEEE Xplore Digital Library

KollektionOxford Journals 2020 Medicine

Zeitschrift / SerieGastroenterology

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(105)

Sprache

Englisch
(105)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

Editorial: Feeling better about NASH

Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial

A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis

All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database

A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study

Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia

Review article: Recommendations for detection, assessment and management of suspected drug‐induced liver injury during clinical trials in oncology patients

Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components

Genome-wide capture sequencing to detect hepatitis C virus at the end of antiviral therapy

Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients

A novel target enrichment strategy in next-generation sequencing through 7-deaza-dGTP-resistant enzymatic digestion

Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B

Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals

High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy

Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection

Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy

Changes in quality of life and sexual health are associated with low‐dose peginterferon therapy and disease progression in patients with chronic hepatitis C

Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status

Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitis

A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients

Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia

Clinical presentation and natural course of hepatocellular carcinoma

Phenotypes of Chronic Hepatitis B in Children From a Large North American Cohort

Aktive Filter

Suchergebnisse filtern